(Q38016781)

27 August 2017

title

The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet (English)

1 reference

27 August 2017

author name string

Christopher S McAllister

series ordinal

1

1 reference

27 August 2017

Martin F Kagnoff

series ordinal

2

1 reference

27 August 2017

publication date

7 June 2012

1 reference

Seminars in Immunopathology

27 August 2017

published in

1 reference

27 August 2017

volume

34

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

581-600

1 reference

Celiac disease: pathogenesis of a model immunogenetic disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Small-intestinal histopathology and mortality risk in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Integration of genetic and immunological insights into a model of celiac disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Analysis and clinical effects of gluten in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Identification of tissue transglutaminase as the autoantigen of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The histopathology of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Tissue-mediated control of immunopathology in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Concordance, disease progression, and heritability of coeliac disease in Italian twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Newly identified genetic risk variants for celiac disease related to the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Multiple common variants for celiac disease influencing immune gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Potential celiac patients: a model of celiac disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Shared and distinct genetic variants in type 1 diabetes and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Protective effect of breast feeding against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Infectious associations of Celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Rotavirus and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Children born in the summer have increased risk for coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Interferon-alpha drives T cell-mediated immunopathology in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Chronic hepatitis C virus and celiac disease, is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Celiac disease: how complicated can it get?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Refractory coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Classification and management of refractory coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Commercial assays to assess gluten content of gluten-free foods: why they are not created equal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Cereal seed storage proteins: structures, properties and role in grain utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Risk of malignancy in patients with celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Limited availability and higher cost of gluten-free foods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Nutritional and dietary aspects of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Protein engineering of improved prolyl endopeptidases for celiac sprue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A food-grade enzyme preparation with modest gluten detoxification properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Enterocytes' tight junctions: From molecules to diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Transglutaminase 2 inhibitors and their therapeutic role in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Mechanism for the inhibition of transglutaminase 2 by cystamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Gene disruption of tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Unexpected role of surface transglutaminase type II in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Novel therapies for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Activation and inhibition of transglutaminase 2 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Assessing high affinity binding to HLA-DQ2.5 by a novel peptide library based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Interferon-gamma regulation of intestinal epithelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Matrix metalloproteinase pattern in celiac duodenal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

In vitro induction of regulatory T cells by anti-CD3 antibody in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Induction of immunological tolerance by oral anti-CD3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

The 'hygiene hypothesis' for autoimmune and allergic diseases: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Gut microflora associated characteristics in children with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

A distinctive 'microbial signature' in celiac pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Helminth-host immunological interactions: prevention and control of immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Budesonide in the treatment of refractory celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Small intestinal release mesalamine for the treatment of refractory celiac disease type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Evaluation of Cladribine treatment in refractory celiac disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Celiac disease and autoimmune thyroid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Epithelial Tight Junction Structure in the Jejunum of Children with Acute and Treated Celiac Sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Gluten-free Sourdough Wheat Baked Goods Appear Safe for Young Celiac Patients: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0318-8

Successful treatment of coeliac disease by allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

12 December 2020

The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues

1 reference

12 December 2020

Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation

1 reference

12 December 2020

A major role for matrix metalloproteinases in T cell injury in the gut.

1 reference

12 December 2020

Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet

1 reference

12 December 2020

HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis

1 reference

12 December 2020

Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response

1 reference

12 December 2020

Human zonulin, a potential modulator of intestinal tight junctions.

1 reference

12 December 2020

Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease

1 reference

12 December 2020

The histopathology of coeliac disease: time for a standardized report scheme for pathologists

1 reference

12 December 2020

Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis

1 reference

12 December 2020

Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial

1 reference

12 December 2020

Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease

1 reference

12 December 2020

The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population.

1 reference

12 December 2020

Changing presentation of adult celiac disease

1 reference

12 December 2020

Coeliac disease: a histological follow-up study

1 reference

12 December 2020

Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.

1 reference

12 December 2020

Natalizumab in the treatment of Crohn's disease.

1 reference

12 December 2020

Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study

1 reference

12 December 2020

Video capsule endoscopy in celiac disease: current clinical practice

1 reference

12 December 2020

Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease

1 reference

12 December 2020

Seasonality of birth month of children with celiac disease differs from that in the general population and between sexes and is linked to family history and environmental factors

1 reference

12 December 2020

Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma

1 reference

12 December 2020

High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study

1 reference

12 December 2020

Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule

1 reference

12 December 2020

Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.?

1 reference

12 December 2020

Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol

1 reference

12 December 2020

Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults

1 reference

12 December 2020

Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity

1 reference

12 December 2020

Contribution of the MHC region to the familial risk of coeliac disease

1 reference

12 December 2020

Natural Variation in Toxicity of Wheat: Potential for Selection of Nontoxic Varieties for Celiac Disease Patients

1 reference

12 December 2020

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease

1 reference

12 December 2020

The effect of a wheat-gluten-free diet in adult idiopathic steatorrhoea; a study of 22 cases

1 reference

12 December 2020

Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library

1 reference

12 December 2020

Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity

1 reference

12 December 2020

Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice

1 reference

12 December 2020

Increased protein expression of matrix metalloproteinases -1, -3, and -9 and TIMP-1 in patients with gluten-sensitive enteropathy

1 reference

12 December 2020

Paracellular versus Transcellular Intestinal Permeability to Gliadin Peptides in Active Celiac Disease

1 reference

12 December 2020

10.1007/S00281-012-0318-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1008761735

0 references

1 reference